We take a look at 4 Pharma & Biotech companies whose share prices rallied in October on the back of positive announcements.

The Indian pharmaceutical market (IPM) registered a 6.1 per cent value growth in October 2024, with major therapies showing ...

All doses of Novo Nordisk’s blockbuster diabetes and obesity drugs were listed as available on the FDA shortage list as of ...

Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

A new solution to supply chain waste in pharma, Lineage’s first earnings post-IPO and the NFL’s favorite treat.

Verona Pharma (Nasdaq: VRNA) is already recording millions of dollars in revenue after launching its lead drug in August ...

Catch up on all the biggest pharma news to hit the industry last month, spanning from new acquisitions, insights on the NHS ...

Independent advisers to the U.S. Food and Drug Administration on Thursday voted against recommending Lexicon Pharmaceuticals' ...

ASX healthcare stocks underperform, but optimism grows as Uscom, Respiri, Hitiq report mixed results and Artrya, Nyrada make ...

ANIP may be acquired soon with a potential offer exceeding $8 billion and contingent on FDA approval of a new drug filed in ...

Pharmaceutical management expert Kenneth Getz shares insights on broader trends in the pharma sector influencing the recent wave of layoffs.